Resources

Novel Coronavirus (COVID-19) Patient Tracking Report – Wave 3

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how the experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have evolved over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Patients with Mild to Severe Illnesses
  • Sample Size:
    • 152 Total Patients (Previous Waves: 159, 152)
      • 84 Mild to Moderate Patients (Previous Wave: 83, 77)
      • 68 Moderate to Severe Patients (Previous Wave: 76, 75)
  • Fielding Period:
    • October 7th – 8th

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Name(Required)
This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more